FIELD: medicine, pharmacy. SUBSTANCE: invention relates with injection form of streptocide. Medicinal preparation has γ-form of streptocide at the particle size less than 0.1 mcm, low-molecular polyvinylpyrrolidone and water for injection at the following ratio of components, wt.-%: g-form of streptocide 1.5-2.5; low-molecular polyvinylpyrrolidone 2.0-4.0, and water for injection - the rest. EFFECT: high bioavailability, absence of by-side effect.
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION SHOWING ANTIMICROBIAL EFFECT | 1993 |
|
RU2061476C1 |
SUSPENDED METHYLURACIL FORMULATION | 1992 |
|
RU2007998C1 |
COMPOSITION FOR CAPSULES | 1996 |
|
RU2145847C1 |
METHYLURACIL LINIMENT | 1992 |
|
RU2007997C1 |
COMPOSITION FOR CAPSULES | 1996 |
|
RU2145846C1 |
METHOD OF TESTING CHEMICAL IDENTICAL DRUGS FOR BIOLOGICAL INEQUIVALENCE | 1990 |
|
RU2027184C1 |
COMPOUND FOR CAPSULES | 1996 |
|
RU2363452C2 |
COMPOSITION SHOWING WOUND-HEALING AND ANTIINFLAMMATORY EFFECT | 1994 |
|
RU2097055C1 |
METHOD OF OBTAINING MEDICINAL AGENT IN POWDER FORM | 0 |
|
SU1165399A1 |
COMPOSITION FOR TREATING BACTERIAL INFECTIONS IN ANIMALS | 2009 |
|
RU2397753C1 |
Authors
Dates
1996-06-10—Published
1993-01-20—Filed